The Vanguard Group Discloses Holdings in Mural Oncology PLC

The Vanguard Group, Inc. has disclosed its position in Mural Oncology PLC through a Form 8.3 filing with the Irish Takeover Panel. As of June 9, 2025, Vanguard controls 772,915 ordinary shares of Mural Oncology, representing 4.48% of the company's relevant securities. This disclosure is in line with Rule 8.3 of the Irish Takeover Panel Act, applicable to entities holding 1% or more of the relevant securities.

No additional parties related to the offer are disclosed by Vanguard, and there are no other interests or short positions outside this tranche. Recent transactions involve purchasing 80 shares and selling 32 shares, both at a price of 2.61 USD per share. Furthermore, there are no cash-settled or stock-settled derivative transactions disclosed, nor are there agreements or understandings related to options or derivatives.